Neurotech Industry Conference

Hi all, I really, really recommend that you attend this conference. It's a great opportunity.

I have a code for a special $100 discount for MIT Neurotech Club members if you send me an email (eesley at mit).


Register Today View Agenda More Information
Join hundreds of executives, investors, and other leaders from across the neurotech industry at the only partnering and investing conference including drugs, devices and diagnostics for the brain and nervous system.

The Neurotech Industry Investing and Partnering Conference will take place on May 8-9 at the Westin Copley Place in Boston.

Hear about next generation treatments for Alzheimer's, addiction, anxiety, depression, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, traumatic brain injury, spinal cord injury, Parkinson's and other brain-related illnesses.

Hear from over 50 neurotech executives and investors in these sessions
- Investing in Neurotech
- Addiction, Impluse Control and Obesity
- Drug Delivery and the Blood Brain Barrier
- Alzheimer's and Cognitive Disorders
- Paving the Way in New Markets
- Insomnia and Sleep Disorders
- Traumatic Brain and Spinal Cord Injury
- Partnering and Licensing in Neurotech
- Next Generation Neuropsychiatry
- Effective Global Clinical Trial Design
- Pain: Acute, Chronic and Neuropathic
- Neurotech Public Policy 2008

Presenting companies include

Robert Alonso, President and CEO, Yaupon Therapeutics
Gary Ascani, President and CEO, Banyan Biomarkers
Kees Been, President and CEO, EnVivo Therapeutics
Kerrie Brady, President and CEO, Traxion Therapeutics
Kenneth Chahine, President and CEO, Avigen
Chris Chavez, President and CEO, Advanced Neuromodulation Systems*
Donald deBethizy, President and CEO, Targacept
Christopher deCharms, President and CEO, Omneuron
Christine de los Reyes, Managing Director, Biotech Partnering Solutions
Philip Devlin, EVP and General Manager, Aspect Neuroscience
Frank Eeckman, Director, NeuroInsights, Centient Biotech Investor
Pieter Gaillard, President and CEO, toBBB
Paul Gilbert, CEO, Medavante
David Hale, Executive Chairman, Somaxon
Michael Kauffman, President and CEO, Epix Pharmaceuticals
Jonathan Kil, President and CEO, Sound Pharmaceuticals
Mark Knudson, President and CEO, Enteromedics
Elliot Krames, President, International Neuromodulation Society
Lothar Krinke, VP Business Development, Medtronic Neurological
Manuel Lopez-Figueroa, Investment Professional, Bay City Capital
Andres Lozano, President and CEO, Functional Neuroscience, Inc.
Casey Crawford Lynch, Managing Director, NeuroInsights
Zack Lynch, Executive Director, Neurotechnology Industry Organization
Sharon Mates, Chairman and CEO, Intra-Cellular Therapies
Cris McReynolds, President & CEO, Satoris
Erich Mohr, President & CEO, Med-Genesis
Dan Moore, President and CEO, Cyberonics
Karoly Nikolich, President and CEO, Amnestix
Dan O'Connell, Managing Director, NeuroVentures Capital
Suzan Onel, Partner, K&L Gates, NIO FDA Policy Counsel
Vincent Owens, President and CEO, Intelect Medical
Art Pappas, Managing Partner, Pappas Ventures
Mark Pykett, President and COO, Alseres Pharmaceuticals
Roger Quy, General Partner, Technology Partners
Srinivas Rao, Chief Scientific Officer, Cypress Bioscience
Wendye Robbins, President and CEO, Limerick Neuroscience
Daniel Ritter, Partner, K&L Gates, NIO Public Policy Counsel
Luca Santarelli, Global Head, Clinical Research, CNS, Hoffmann-La Roche
Jim Schoeneck, President and CEO, BrainCells, Inc.
David Schultz, Senior Director, Worldwide Business Development, Pfizer
Rajeev Shah, Senior Analyst, RA Capital
Uzi Sofer, CEO, Brainsway
Tim Surgenor, President and CEO, Cyberkinetics Neurotechnology Systems
Tim Tasker, Executive Vice President Clinical Development, Evotec
Gary Tollefson, President and CEO, Orexigen
Lars Wahlberg, Executive Vice President and COO, NsGene
*indicates invited and in process of confirming


This market defining conference features keynotes on the state of the industry, cutting edge company presentations, and panel discussions on a comprehensive selection of commercial neuroscience topics.

Click here to register today at early rates

Gold Sponsors
sponsors
MIBR

Conference Organized by: NeuroInsights